These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2207014)

  • 1. The successful treatment of a case of very severe aplastic anaemia with granulocyte-macrophage colony stimulating factor and anti-lymphocyte globulin.
    Potter MN; Mott MG; Oakhill A
    Br J Haematol; 1990 Aug; 75(4):618-9. PubMed ID: 2207014
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aplastic anemia].
    Kuriya S
    Nihon Naika Gakkai Zasshi; 1994 Mar; 83(3):377-81. PubMed ID: 7963958
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomised placebo controlled study of RH-GM-CSF following ALG in the treatment of aplastic anaemia.
    Gordon-Smith EC; Yandle A; Milne A; Speck B; Marmont A; Willemze R; Kolb H
    Bone Marrow Transplant; 1991; 7 Suppl 2():78-80. PubMed ID: 1878731
    [No Abstract]   [Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor in the sera of patients with aplastic anemia.
    Schrezenmeier H; Raghavachar A; Heimpel H
    Clin Investig; 1993 Feb; 71(2):102-8. PubMed ID: 8461622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-thymocyte globulin, cyclosporin A and granulocyte colony-stimulating factor for severe aplastic anaemia complicating paediatric liver transplantation.
    Hadzic N; Layton M; Heaton ND; Rela M; Baker AJ; Mieli-Vergani G
    Eur J Pediatr; 1998 Feb; 157(2):107-8. PubMed ID: 9504782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in biology and therapy of aplastic anemia and other conditions of bone marrow failure].
    Robak T
    Postepy Hig Med Dosw; 1992; 46(1):21-51. PubMed ID: 1641375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rejection of the second allogeneic graft in a patient with severe aplastic anemia reversed by antilymphocyte globulin and donor lymphocyte infusions.
    Ljungman P; Lawler M; Lönnqvist B; Ringdén O; Shanwell A
    Bone Marrow Transplant; 1996 Dec; 18(6):1179-81. PubMed ID: 8971392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro granulocyte-macrophage colony-stimulating factor production by peripheral blood mononuclear cells in aplastic anemia.
    Kojima S; Matsuyama T; Kodera Y
    Acta Haematol; 1994; 91(4):175-80. PubMed ID: 7976114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of haemopoietic growth factors for aplastic anaemia.
    Foot AB; Potter MN; Mott MG; Oakhill A
    Lancet; 1994 Sep; 344(8924):757. PubMed ID: 7915805
    [No Abstract]   [Full Text] [Related]  

  • 10. Methimazole-induced severe aplastic anemia: unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor.
    Escobar-Morreale HF; Bravo P; García-Robles R; García-Laraña J; de la Calle H; Sancho JM
    Thyroid; 1997 Feb; 7(1):67-70. PubMed ID: 9086574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of response of aplastic anemia patients to antilymphocyte globulin with in vitro lymphocyte stimulatory effect: predictive value of in vitro test for clinical response.
    Abe T; Matsuoka H; Kojima S; Kamachi Y; Tsuge I; Kodera Y; Matsuyama T
    Blood; 1991 May; 77(10):2225-30. PubMed ID: 2029581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe aplastic anemia with antilymphocyte globulin and androgens.
    Gluckman E; Devergie A; Faille A; Barrett AJ; Bonneau M; Boiron M; Bernard J
    Exp Hematol; 1978 Sep; 6(8):679-87. PubMed ID: 361428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of immunosuppressive therapy for aplastic anemia].
    Teramura M; Saito H; Kobayashi S; Hoshino S; Oshimi K; Mizoguchi H
    Rinsho Ketsueki; 1993 Mar; 34(3):273-6. PubMed ID: 7683063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antilymphocyte globulin treatment in children with aplastic anemia].
    Kojima S; Fukuda M; Horibe K; Matsuyama K; Miyamura K; Kodera Y
    Rinsho Ketsueki; 1988 May; 29(5):676-81. PubMed ID: 3216493
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia.
    Doney K; Storb R; Appelbaum FR; Buckner CD; Sanders J; Singer J; Hansen JA
    Br J Haematol; 1993 Sep; 85(1):182-4. PubMed ID: 8251389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An effective antilymphocyte globulin treatment in a case of aplastic anemia].
    Toyama K; Tauchi T; Fujieda H; Yaguchi M; Kawaguchi M; Miyazawa K; Ohyashiki J; Ohyashiki K; Aoki I
    Rinsho Ketsueki; 1988 Jan; 29(1):85-90. PubMed ID: 3385939
    [No Abstract]   [Full Text] [Related]  

  • 18. Gender and response to antilymphocyte globulin (ALG) for severe aplastic anaemia.
    Nissen C; Gratwohl A; Tichelli A; Stebler C; Würsch A; Moser Y; Dalle Carbonare V; Signer E; Buser M; Ritz R
    Br J Haematol; 1993 Feb; 83(2):319-25. PubMed ID: 7681318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lactoferrin content in neutropenic patients: effects of treatment with recombinant granulocyte-macrophage colony-stimulating factor.
    Bezwoda WR; Dajee D
    Mol Biother; 1992 Jun; 4(2):103-6. PubMed ID: 1515094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone remodelling after growth factor and cyclosporine A therapy for aplastic anemia.
    Derfus BA; Csuka ME; Carrera GF; Hanson GA; Smith RE
    J Rheumatol; 1991 May; 18(5):738-42. PubMed ID: 1865422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.